Association between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure with Reduced Ejection Fraction

OBJECTIVE: Our objective is to describe the short-term, health status benefits of ARNI initiation in patients with heart failure and reduced ejection fraction (HFrEF). BACKGROUND: While sacubitril/valsartan, a neprilysin inhibitor (ARNI), improved patients’ health status (compared with enalapril) at...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JACC Heart Fail
Autors principals: Khariton, Yevgeniy, Fonarow, Gregg C., Arnold, Suzanne V., Hellkamp, Ann, Nassif, Michael E., Sharma, Puza P., Butler, Javed, Thomas, Laine, Duffy, Carol I, DeVore, Adam, Albert, Nancy M., Patterson, J. Herbert, Williams, Fredonia B., McCague, Kevin, Spertus, John A.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7122134/
https://ncbi.nlm.nih.gov/pubmed/31521679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2019.05.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars